Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Knowing what percentages to allocate to stocks and bonds helps in portfolio balance. Learn effective allocation strategies today.
28,656 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Jay-Z, now valued at roughly $2.8 billion, argues that demonizing wealth misses the bigger fixes to inequality. The s...
Aave asks a New York court to lift a restraining order on ETH set aside for victims of a DeFi breach, arguing the ass...
As the AI infrastructure boom intensifies, communities push back against giant data centers. Kevin O’Leary’s Stratos ...
A swarm over the North Lawn turns a politics moment into a money lesson. Learn practical steps to build resilience, f...
A November-like standoff erupts as MRED suspends Zillow’s access to Chicagoland listing data, potentially reshaping h...
A new survey shows almost 4 in 10 millennials take secret vacations while appearing online, forcing firms to rethink ...
A podcast recap attributes a Bezos stance to exempting the bottom half from federal income taxes, highlighting a broa...
A former minutes correspondent doesn't express confidence in the long-term future of 60 Minutes as advertisers shift ...
As market volatility rattles mid-year trading, a growing cohort of traders is turning to funded trading accounts. Thi...
Buffini & Company hires three senior leaders to accelerate its referral-based coaching model in a rapidly evolving AI...
India restricts Telegram access ahead of the NEET-UG re-exam, hitting hundreds of millions of users and sending Gram ...